Table of Contents Chapter 1 Overview of Antimalarial Drug 1.1 Definition of Antimalarial Drug in This Report 1.2 Commercial Types of Antimalarial Drug 1.2.1 Plasmodium Falciparum 1.2.2 Plasmodium Vivax 1.2.3 Plasmodium Malariae 1.2.4 Plasmodium Ovale 1.3 Downstream Application of Antimalarial Drug 1.3.1 Hospital Pharmacy 1.3.2 Retail Pharmacy 1.3.3 E-Commerce 1.3.4 Others 1.4 Development History of Antimalarial Drug 1.5 Market Status and Trend of Antimalarial Drug 2013-2023 1.5.1 United States Antimalarial Drug Market Status and Trend 2013-2023 1.5.2 Regional Antimalarial Drug Market Status and Trend 2013-2023 Chapter 2 United States Market Status and Forecast by Regions 2.1 Market Status of Antimalarial Drug in United States 2013-2017 2.2 Consumption Market of Antimalarial Drug in United States by Regions 2.2.1 Consumption Volume of Antimalarial Drug in United States by Regions 2.2.2 Revenue of Antimalarial Drug in United States by Regions 2.3 Market Analysis of Antimalarial Drug in United States by Regions 2.3.1 Market Analysis of Antimalarial Drug in New England 2013-2017 2.3.2 Market Analysis of Antimalarial Drug in The Middle Atlantic 2013-2017 2.3.3 Market Analysis of Antimalarial Drug in The Midwest 2013-2017 2.3.4 Market Analysis of Antimalarial Drug in The West 2013-2017 2.3.5 Market Analysis of Antimalarial Drug in The South 2013-2017 2.3.6 Market Analysis of Antimalarial Drug in Southwest 2013-2017 2.4 Market Development Forecast of Antimalarial Drug in United States 2018-2023 2.4.1 Market Development Forecast of Antimalarial Drug in United States 2018-2023 2.4.2 Market Development Forecast of Antimalarial Drug by Regions 2018-2023 Chapter 3 United States Market Status and Forecast by Types 3.1 Whole United States Market Status by Types 3.1.1 Consumption Volume of Antimalarial Drug in United States by Types 3.1.2 Revenue of Antimalarial Drug in United States by Types 3.2 United States Market Status by Types in Major Countries 3.2.1 Market Status by Types in New England 3.2.2 Market Status by Types in The Middle Atlantic 3.2.3 Market Status by Types in The Midwest 3.2.4 Market Status by Types in The West 3.2.5 Market Status by Types in The South 3.2.6 Market Status by Types in Southwest 3.3 Market Forecast of Antimalarial Drug in United States by Types Chapter 4 United States Market Status and Forecast by Downstream Industry 4.1 Demand Volume of Antimalarial Drug in United States by Downstream Industry 4.2 Demand Volume of Antimalarial Drug by Downstream Industry in Major Countries 4.2.1 Demand Volume of Antimalarial Drug by Downstream Industry in New England 4.2.2 Demand Volume of Antimalarial Drug by Downstream Industry in The Middle Atlantic 4.2.3 Demand Volume of Antimalarial Drug by Downstream Industry in The Midwest 4.2.4 Demand Volume of Antimalarial Drug by Downstream Industry in The West 4.2.5 Demand Volume of Antimalarial Drug by Downstream Industry in The South 4.2.6 Demand Volume of Antimalarial Drug by Downstream Industry in Southwest 4.3 Market Forecast of Antimalarial Drug in United States by Downstream Industry Chapter 5 Market Driving Factor Analysis of Antimalarial Drug 5.1 United States Economy Situation and Trend Overview 5.2 Antimalarial Drug Downstream Industry Situation and Trend Overview Chapter 6 Antimalarial Drug Market Competition Status by Major Players in United States 6.1 Sales Volume of Antimalarial Drug in United States by Major Players 6.2 Revenue of Antimalarial Drug in United States by Major Players 6.3 Basic Information of Antimalarial Drug by Major Players 6.3.1 Headquarters Location and Established Time of Antimalarial Drug Major Players 6.3.2 Employees and Revenue Level of Antimalarial Drug Major Players 6.4 Market Competition News and Trend 6.4.1 Merger, Consolidation or Acquisition News 6.4.2 Investment or Disinvestment News 6.4.3 New Product Development and Launch Chapter 7 Antimalarial Drug Major Manufacturers Introduction and Market Data 7.1 Pfizer 7.1.1 Company profile 7.1.2 Representative Antimalarial Drug Product 7.1.3 Antimalarial Drug Sales, Revenue, Price and Gross Margin of Pfizer 7.2 GlaxoSmithKline 7.2.1 Company profile 7.2.2 Representative Antimalarial Drug Product 7.2.3 Antimalarial Drug Sales, Revenue, Price and Gross Margin of GlaxoSmithKline 7.3 Ranbaxy Laboratories 7.3.1 Company profile 7.3.2 Representative Antimalarial Drug Product 7.3.3 Antimalarial Drug Sales, Revenue, Price and Gross Margin of Ranbaxy Laboratories 7.4 Ipca Laboratories Ltd 7.4.1 Company profile 7.4.2 Representative Antimalarial Drug Product 7.4.3 Antimalarial Drug Sales, Revenue, Price and Gross Margin of Ipca Laboratories Ltd 7.5 Zydus Cadila 7.5.1 Company profile 7.5.2 Representative Antimalarial Drug Product 7.5.3 Antimalarial Drug Sales, Revenue, Price and Gross Margin of Zydus Cadila 7.6 Merck KGaA 7.6.1 Company profile 7.6.2 Representative Antimalarial Drug Product 7.6.3 Antimalarial Drug Sales, Revenue, Price and Gross Margin of Merck KGaA 7.7 Novartis AG 7.7.1 Company profile 7.7.2 Representative Antimalarial Drug Product 7.7.3 Antimalarial Drug Sales, Revenue, Price and Gross Margin of Novartis AG 7.8 Alvizia Health Care 7.8.1 Company profile 7.8.2 Representative Antimalarial Drug Product 7.8.3 Antimalarial Drug Sales, Revenue, Price and Gross Margin of Alvizia Health Care 7.9 Bayer 7.9.1 Company profile 7.9.2 Representative Antimalarial Drug Product 7.9.3 Antimalarial Drug Sales, Revenue, Price and Gross Margin of Bayer 7.10 Roche 7.10.1 Company profile 7.10.2 Representative Antimalarial Drug Product 7.10.3 Antimalarial Drug Sales, Revenue, Price and Gross Margin of Roche Chapter 8 Upstream and Downstream Market Analysis of Antimalarial Drug 8.1 Industry Chain of Antimalarial Drug 8.2 Upstream Market and Representative Companies Analysis 8.3 Downstream Market and Representative Companies Analysis Chapter 9 Cost and Gross Margin Analysis of Antimalarial Drug 9.1 Cost Structure Analysis of Antimalarial Drug 9.2 Raw Materials Cost Analysis of Antimalarial Drug 9.3 Labor Cost Analysis of Antimalarial Drug 9.4 Manufacturing Expenses Analysis of Antimalarial Drug Chapter 10 Marketing Status Analysis of Antimalarial Drug 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List Chapter 11 Report Conclusion Chapter 12 Research Methodology and Reference 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Reference